KRAS, NRAS and BRAF Mutation Prevalence and its Clinicopathological Association in Colorectal Carcinoma with Emphasis on Tumor Budding

被引：0
|
作者：
Ghafoor, Mariam [1 ]
Ajmal, Namra [1 ]
Wang, Zixuan [2 ]
Bashir, Babar [3 ]
Lin, Daniel [3 ]
Peiper, Stephen [4 ]
Jiang, Wei [1 ]
Ambelil, Manju [2 ]
机构：
[1] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[3] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA
[4] Sidney Kimmel Med Coll, Philadelphia, PA USA
来源：
LABORATORY INVESTIGATION | 2022年 / 102卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
422
引用
收藏
页码：458 / 459
页数：2
相关论文
共 50 条
  • [1] KRAS, NRAS and BRAF Mutation Prevalence and its Clinicopathological Association in Colorectal Carcinoma with Emphasis on Tumor Budding
    Ghafoor, Mariam
    Ajmal, Namra
    Wang, Zixuan
    Bashir, Babar
    Lin, Daniel
    Peiper, Stephen
    Jiang, Wei
    Ambelil, Manju
    [J]. MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 458 - 459
  • [2] KRAS, NRAS and BRAF Mutation Prevalence and its Clinicopathological Association in Colorectal Carcinoma with Emphasis on Tumor Budding
    Ghafoor, Mariam
    Ajmal, Namra
    Wang, Zixuan
    Bashir, Babar
    Lin, Daniel
    Peiper, Stephen
    Jiang, Wei
    Ambelil, Manju
    [J]. MODERN PATHOLOGY, 2022, 35 : 458 - 459
  • [3] Association between KRAS, NRAS, BRAF mutation status and clinicopathological prognostic factors in colorectal carcinoma in Turkish population
    Kocabey, D. Unal
    Cakir, E.
    Dilek, F. H.
    Kucukzeybek, B. Bolat
    Calli, A.
    [J]. VIRCHOWS ARCHIV, 2019, 475 : S237 - S237
  • [4] BRAF/KRAS Mutation, MSI/MSS Status and Tumor Budding in Colorectal Carcinoma
    Zhao, Qing
    Yang, Shi
    Ponchiardi, Cecilia
    O'Brien, Michael
    [J]. LABORATORY INVESTIGATION, 2015, 95 : 201A - 202A
  • [5] BRAF/KRAS Mutation, MSI/MSS Status and Tumor Budding in Colorectal Carcinoma
    Zhao, Qing
    Yang, Shi
    Ponchiardi, Cecilia
    O'Brien, Michael
    [J]. MODERN PATHOLOGY, 2015, 28 : 201A - 202A
  • [6] KRAS, NRAS, and BRAF mutation prevalence, clinicopathological association, and their application in a predictive model in Mexican patients with metastatic colorectal cancer: A retrospective cohort study
    Sanchez-Ibarra, Hector Eduardo
    Jiang, Xianli
    Gallegos-Gonzalez, Elena Yareli
    Cavazos-Gonzalez, Adriana Carolina
    Chen, Yenho
    Morcos, Faruck
    Barrera-Saldana, Hugo Alberto
    [J]. PLOS ONE, 2020, 15 (07):
  • [7] Correlation between clinicopathological features and KRAS, NRAS, and BRAF mutation status in Chinese colorectal cancer patients
    Zhu, Xiaoli
    Meng, Xianke
    Xiang, Wenqiang
    Dai, Weixing
    Bai, Qianming
    Sheng, Weiqi
    Lu, Yongming
    Qi, Peng
    Wu, Lijing
    Cai, Guoxiang
    Zhou, Xiaoyan
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (05): : 2839 - 2845
  • [8] KRAS, NRAS, BRAF, and PIK3CA mutation rates, clinicopathological association, and their prognostic value in Iranian colorectal cancer patients
    Abbasabadi, Zohreh Mirzapoor .
    Asl, Dariush Hamedi
    Rahmani, Babak
    Shahbadori, Rozhin
    Karami, Sara
    Peymani, Amir
    Taghizadeh, Sara
    Rad, Fatemeh Samiee
    [J]. JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2023, 37 (05)
  • [9] Determination of the Prevalence of Microsatellite Instability, BRAF and KRAS/NRAS Mutation Status in Patients with Colorectal Cancer in Slovakia
    Rendek, Tomas
    Saade, Rami
    Pos, Ondrej
    Kolnikova, Georgina
    Urbanova, Monika
    Budis, Jaroslav
    Mihok, Luboslav
    Tomas, Miroslav
    Szemes, Tomas
    Repiska, Vanda
    [J]. CANCERS, 2024, 16 (06)
  • [10] KRAS, NRAS, BRAF mutation spectrum in Georgian patients with metastatic colorectal cancer
    Agladze, D.
    Iordanishvili, S.
    Margvelashvili, L.
    Kldiashvili, E.
    Kvlividze, O.
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 939 - 940
12345